Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.02 USD | -3.69% |
|
-6.44% | +134.20% |
Jun. 12 | Vera Therapeutics, Inc. Appoints Christy Oliger to the Board | CI |
May. 28 | Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment | MT |
Evolution of the average Target Price on Vera Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Vera Therapeutics, Inc.
Wedbush | |
Oppenheimer | |
Raymond James | |
Cantor Fitzgerald | |
Jefferies & Co. | |
HC Wainwright | |
Guggenheim | |
JPMorgan Chase | |
Cowen | |
Evercore ISI |
EPS Revisions
- Stock Market
- Equities
- VERA Stock
- Consensus Vera Therapeutics, Inc.